Christopher Leveque

1.6k total citations
27 papers, 659 citations indexed

About

Christopher Leveque is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Biochemistry. According to data from OpenAlex, Christopher Leveque has authored 27 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Biochemistry. Recurrent topics in Christopher Leveque's work include Blood transfusion and management (4 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (3 papers) and Central Venous Catheters and Hemodialysis (3 papers). Christopher Leveque is often cited by papers focused on Blood transfusion and management (4 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (3 papers) and Central Venous Catheters and Hemodialysis (3 papers). Christopher Leveque collaborates with scholars based in United States, Mexico and France. Christopher Leveque's co-authors include Swaminathan P. Iyer, Eric Salazar, Stephen C. Pflugfelder, Kapil N. Bhalla, Santhana G.T. Devaraj, Warren Fiskus, James M. Musser, Duc T. Nguyen, Paul Christensen and John Rogers and has published in prestigious journals such as Blood, Neurology and American Journal Of Pathology.

In The Last Decade

Christopher Leveque

26 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Leveque United States 12 203 188 157 89 74 27 659
Maria Prendecki United Kingdom 17 399 2.0× 118 0.6× 61 0.4× 99 1.1× 63 0.9× 50 872
Changcheng Zheng China 14 340 1.7× 73 0.4× 290 1.8× 146 1.6× 13 0.2× 65 743
Moussab Damlaj Saudi Arabia 13 190 0.9× 101 0.5× 193 1.2× 91 1.0× 6 0.1× 65 625
Rébecca Sberro‐Soussan France 19 137 0.7× 54 0.3× 122 0.8× 17 0.2× 29 0.4× 49 1.1k
Chung Ying Leung China 7 676 3.3× 175 0.9× 36 0.2× 169 1.9× 31 0.4× 11 1.1k
Naomi Rahimi‐Levene Israel 16 140 0.7× 68 0.4× 164 1.0× 32 0.4× 13 0.2× 51 630
Wenjuan He China 7 306 1.5× 37 0.2× 41 0.3× 79 0.9× 30 0.4× 14 513
Friederike Bachmann Germany 14 193 1.0× 57 0.3× 101 0.6× 16 0.2× 63 0.9× 51 741
Melina de Barros Pinheiro Brazil 18 78 0.4× 62 0.3× 152 1.0× 28 0.3× 435 5.9× 46 874
Vernon Louw South Africa 13 104 0.5× 37 0.2× 256 1.6× 51 0.6× 8 0.1× 82 693

Countries citing papers authored by Christopher Leveque

Since Specialization
Citations

This map shows the geographic impact of Christopher Leveque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Leveque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Leveque more than expected).

Fields of papers citing papers by Christopher Leveque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Leveque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Leveque. The network helps show where Christopher Leveque may publish in the future.

Co-authorship network of co-authors of Christopher Leveque

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Leveque. A scholar is included among the top collaborators of Christopher Leveque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Leveque. Christopher Leveque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Salazar, Eric, Paul Christensen, Edward A. Graviss, et al.. (2020). Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality. American Journal Of Pathology. 190(11). 2290–2303. 128 indexed citations
3.
Ipe, Tina S., et al.. (2019). Better Blood Bank Administration Review and Bridging Epic Using QUEries (BB-BARBEQUE). American Journal of Clinical Pathology. 152(Supplement_1). S9–S9. 1 indexed citations
4.
Salazar, Eric, et al.. (2018). The utility of therapeutic plasma exchange for amphotericin B overdose. Transfusion and Apheresis Science. 57(6). 756–758. 6 indexed citations
5.
Salazar, Eric, et al.. (2018). Ultrasound view of vein collapse during therapeutic apheresis performed with peripheral access. Transfusion. 58(6). 1570–1571. 2 indexed citations
6.
Nan, Xinyu, Qian Qin, Joe Ensor, et al.. (2017). Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis – a retrospective study from a tertiary center. Leukemia & lymphoma. 58(9). 2110–2117. 25 indexed citations
7.
Salazar, Eric, David B. Cohen, Tina S. Ipe, & Christopher Leveque. (2017). Therapeutic Plasma Exchange for Potential Human Leukocyte Antigen Antibody-Mediated Rejection in Liver Transplant Patients. American Journal of Clinical Pathology. 147(suppl_2). S163–S163. 2 indexed citations
8.
Thonhoff, Jason R., David R. Beers, Weihua Zhao, et al.. (2016). Plasmapheresis Improves the Suppressive Function of Regulatory T Cells in Patients with Fast-Progressing Amyotrophic Lateral Sclerosis (P3.183). Neurology. 86(16_supplement). 1 indexed citations
9.
Fiskus, Warren, Sunil Sharma, Jun Qi, et al.. (2014). BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD. Molecular Cancer Therapeutics. 13(10). 2315–2327. 112 indexed citations
10.
Fiskus, Warren, S. Sharma, Saikat Saha, et al.. (2014). Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells. Leukemia. 29(6). 1267–1278. 82 indexed citations
12.
Masud, Faisal, et al.. (2011). Establishing a Culture of Blood Management Through Education. American Journal of Medical Quality. 26(5). 349–356. 7 indexed citations
13.
Torre‐Amione, Guillermo, et al.. (2010). Therapeutic plasma exchange a potential strategy for patients with advanced heart failure. Journal of Clinical Apheresis. 25(6). 323–330. 22 indexed citations
14.
Leveque, Christopher, et al.. (2009). Corneal nerve regeneration in neurotrophic keratopathy following autologous plasma therapy. British Journal of Ophthalmology. 94(5). 584–591. 58 indexed citations
15.
Leveque, Christopher, et al.. (2003). National Society of Black Engineers Community Outreach Program. 2. 12D4/1–12D4/6. 3 indexed citations
16.
Safi, Hazim J., Dimitrios Iliopoulos, Shankar P. Gopinath, et al.. (1995). Retrograde cerebral perfusion during profound hypothermia and circulatory arrest in pigs. The Annals of Thoracic Surgery. 59(5). 1107–1112. 31 indexed citations
17.
Leveque, Christopher & David H. Yawn. (1992). Limiting Homologous Blood Exposure. Clinics in Laboratory Medicine. 12(4). 771–785. 3 indexed citations
18.
Petrusa, Emil, et al.. (1991). Evaluation of a Case-Based Course in Transfusion Medicine for Third-Year Medical Students. Laboratory Medicine. 22(7). 475–476. 1 indexed citations
19.
Guillot, Martin, et al.. (1988). [Hypersensitivity pneumopathies ("bird fancier's lung") in children. Diagnostic value of bronchoalveolar lavage].. PubMed. 45(2). 115–7. 1 indexed citations
20.
Haque, Abida K., Sanford A. Rubin, & Christopher Leveque. (1984). Pulmonary Calcification in Long-Term Hemodialysis: A Mimic of Pulmonary Thromboembolism. American Journal of Nephrology. 4(2). 109–113. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026